23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › RHYTHM PHARMACEUTICALS INC. › 2023-2024

RHYTHM PHARMACEUTICALS INC. 2023-2024 Proxy Voting Records

At RHYTHM PHARMACEUTICALS INC.'s shareholder meeting held June 18, 2024, in the 2023-2024 proxy season, 96 asset managers reported how they voted in their SEC Form N-PX filings, covering 300 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — Approval, on an advisory (non-binding) basis, of the compensation of the named executive… — the reporting funds and managers cast 99.6% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings. Page generated November 8, 2026.

  • 8Reported items
  • 96Asset managers
  • 300Fund votes
  • June 18, 2024Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from RHYTHM PHARMACEUTICALS INC. has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore RHYTHM PHARMACEUTICALS INC. in the interactive database Compare manager voting policies

How asset managers voted at the RHYTHM PHARMACEUTICALS INC. 2023-2024 meeting

Each item below shows how the 96 asset managers that disclosed a RHYTHM PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of RHYTHM PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Elect Christophe R. Jean

No official resultsDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 23 asset managers

The 23 asset managers below reported 9,862,511 for, 8,457 withheld, 19,232 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,862,511ABSTAIN: 19,232WITHHOLD: 8,457
Largest asset managers voting on “Elect Christophe R. Jean” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PRIMECAP Odyssey Funds7,368,2120 00For
Federated Hermes1,661,0000 00For
Charles Schwab410,5580 00For
Putnam197,0850 00For
Altium Capital Management LP82,2710 00For
John Hancock9,4580 19,2320Mixed
Global X23,8270 00For
Harbor ETF Trust22,5740 00For
Exchange Place Advisors Trust20,3900 00For
CLEARWATER INVESTMENT TRUST15,8200 00For
Guardian Variable Products Trust15,4000 00For
New York Life10,0610 00For
Bridge Builder Trust9,9480 00For
SEI8,8000 00For
Brighthouse00 08,457Withhold
EA Series Trust1,4240 00For
NORTHERN LIGHTS FUND TRUST II1,3890 00For
Northern Lights Fund Trust IV1,2580 00For
JPMorgan1,2070 00For
Pacer Funds Trust1,0100 00For
Nationwide4860 00For
WILSHIRE MUTUAL FUNDS INC2310 00For
Principal1020 00For

2. Elect Lynn A. Tetrault

No official resultsDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 23 asset managers

The 23 asset managers below reported 9,861,087 for, 8,457 withheld, 20,656 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,861,087ABSTAIN: 20,656WITHHOLD: 8,457
Largest asset managers voting on “Elect Lynn A. Tetrault” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PRIMECAP Odyssey Funds7,368,2120 00For
Federated Hermes1,661,0000 00For
Charles Schwab410,5580 00For
Putnam197,0850 00For
Altium Capital Management LP82,2710 00For
John Hancock9,4580 19,2320Mixed
Global X23,8270 00For
Harbor ETF Trust22,5740 00For
Exchange Place Advisors Trust20,3900 00For
CLEARWATER INVESTMENT TRUST15,8200 00For
Guardian Variable Products Trust15,4000 00For
New York Life10,0610 00For
Bridge Builder Trust9,9480 00For
SEI8,8000 00For
Brighthouse00 08,457Withhold
EA Series Trust00 1,4240Abstain
NORTHERN LIGHTS FUND TRUST II1,3890 00For
Northern Lights Fund Trust IV1,2580 00For
JPMorgan1,2070 00For
Pacer Funds Trust1,0100 00For
Nationwide4860 00For
WILSHIRE MUTUAL FUNDS INC2310 00For
Principal1020 00For

3. Elect Stuart A. Arbuckle

No official resultsDIRECTOR ELECTIONS

Combines 3 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 23 asset managers

The 23 asset managers below reported 9,862,511 for, 8,457 withheld, 19,232 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,862,511ABSTAIN: 19,232WITHHOLD: 8,457
Largest asset managers voting on “Elect Stuart A. Arbuckle” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PRIMECAP Odyssey Funds7,368,2120 00For
Federated Hermes1,661,0000 00For
Charles Schwab410,5580 00For
Putnam197,0850 00For
Altium Capital Management LP82,2710 00For
John Hancock9,4580 19,2320Mixed
Global X23,8270 00For
Harbor ETF Trust22,5740 00For
Exchange Place Advisors Trust20,3900 00For
CLEARWATER INVESTMENT TRUST15,8200 00For
Guardian Variable Products Trust15,4000 00For
New York Life10,0610 00For
Bridge Builder Trust9,9480 00For
SEI8,8000 00For
Brighthouse00 08,457Withhold
EA Series Trust1,4240 00For
NORTHERN LIGHTS FUND TRUST II1,3890 00For
Northern Lights Fund Trust IV1,2580 00For
JPMorgan1,2070 00For
Pacer Funds Trust1,0100 00For
Nationwide4860 00For
WILSHIRE MUTUAL FUNDS INC2310 00For
Principal1020 00For

4. Reapproval of the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan

Combines 2 wordings of this item as funds reported it.

92% of fund votes cast · no official result

FOR
Details: votes by 22 asset managers

The 22 asset managers below reported 9,136,870 for, 743,615 against, 8,457 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,136,870AGAINST: 743,615ABSTAIN: 8,457
Largest asset managers voting on “Reapproval of the Rhythm Pharmaceuticals, Inc. 2017 Equity Incentive Plan” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PRIMECAP Odyssey Funds7,368,2120 00For
Federated Hermes1,661,0000 00For
Charles Schwab0410,558 00Against
Putnam0197,085 00Against
Altium Capital Management LP82,2710 00For
John Hancock028,690 00Against
Global X023,827 00Against
Harbor ETF Trust22,5740 00For
Exchange Place Advisors Trust020,390 00Against
CLEARWATER INVESTMENT TRUST015,820 00Against
Guardian Variable Products Trust015,400 00Against
New York Life010,061 00Against
Bridge Builder Trust09,948 00Against
SEI08,800 00Against
Brighthouse00 8,4570Abstain
EA Series Trust1,4240 00For
NORTHERN LIGHTS FUND TRUST II1,3890 00For
JPMorgan01,207 00Against
Pacer Funds Trust01,010 00Against
Nationwide0486 00Against
WILSHIRE MUTUAL FUNDS INC0231 00Against
Principal0102 00Against

5. Amendment to the 2017 Equity Incentive Plan

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

0% Fund and manager reports combined; may count the same shares twice · no official result

AGAINST
Details: votes by 2 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 1 asset manager voting on “Amendment to the 2017 Equity Incentive Plan” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Northern Lights Fund Trust IV01,258 00Against

Fund voting reports, all 1 managers: 1,258 against.

Institutional-manager reports: 1 asset manager voting on “Amendment to the 2017 Equity Incentive Plan” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ALGERT GLOBAL LLC05,850 00Against

Institutional-manager reports, all 1 managers: 5,850 against.

6. Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 5 wordings of this item as funds reported it.

99.6% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 94 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 21 asset managers voting on “Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Compa” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PRIMECAP Odyssey Funds7,368,2120 00For
Federated Hermes1,661,0000 00For
Charles Schwab410,5580 00For
Putnam197,0850 00For
John Hancock28,6900 00For
Global X23,8270 00For
Harbor ETF Trust22,5740 00For
Exchange Place Advisors Trust20,3900 00For
CLEARWATER INVESTMENT TRUST15,8200 00For
Guardian Variable Products Trust15,4000 00For
New York Life10,0610 00For
Bridge Builder Trust9,9480 00For
SEI8,8000 00For
Brighthouse00 8,4570Abstain
EA Series Trust1,4240 00For
NORTHERN LIGHTS FUND TRUST II1,3890 00For
JPMorgan1,2070 00For
Pacer Funds Trust1,0100 00For
Nationwide4860 00For
WILSHIRE MUTUAL FUNDS INC2310 00For
Principal1020 00For

Fund voting reports, all 21 managers: 9,798,214 for, 8,457 abstained.

Institutional-manager reports: 78 asset managers voting on “Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Compa” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PRIMECAP MANAGEMENT CO/CA/7,727,8910 00For
Federated Hermes1,661,0420 00For
PERCEPTIVE ADVISORS LLC1,560,3490 00For
ORBIMED ADVISORS LLC704,8420 00For
Opaleye Management Inc.505,0000 00For
Charles Schwab410,5580 00For
Northern Trust404,73935 00For
Cormorant Asset Management, LP394,6420 00For
Goldman Sachs366,4600 00For
Putnam204,6430 00For
Wellington173,8540 00For
Samsara BioCapital, LLC172,6470 00For
Altium Capital Management LP82,2710 00For
RICE HALL JAMES & ASSOCIATES, LLC80,6420 00For
NISA INVESTMENT ADVISORS, LLC069,256 00Against
WEDGE CAPITAL MANAGEMENT L L P/NC45,3640 00For
Fulcrum Asset Management LLP42,3030 00For
JPMorgan33,6990 00For
NEW YORK STATE COMMON RETIREMENT FUND32,8110 00For
WASHINGTON STATE INVESTMENT BOARD21,1280 00For
FIDUCIARY TRUST CO20,0000 00For
Ensign Peak Advisors, Inc17,6590 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM014,670 00Against
Wilkinson Global Asset Management LLC12,6800 00For
SEI10,4880 00For

Institutional-manager reports, all 78 managers: 14,751,809 for, 83,961 against, 440 abstained, 128 not voted. Showing the 25 largest; every one is in the interactive database (link above).

7. Advisory Vote on Executive Compensation

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

100% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 2 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 1 asset manager voting on “Advisory Vote on Executive Compensation” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Northern Lights Fund Trust IV1,2580 00For

Fund voting reports, all 1 managers: 1,258 for.

Institutional-manager reports: 1 asset manager voting on “Advisory Vote on Executive Compensation” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
ALGERT GLOBAL LLC5,8500 00For

Institutional-manager reports, all 1 managers: 5,850 for.

8. Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the…

No official resultsAUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% of fund votes cast · no official result

FOR
Details: description as filed, votes by 22 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024

The 22 asset managers below reported 9,880,485 for, 8,457 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,880,485ABSTAIN: 8,457
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for ” at RHYTHM PHARMACEUTICALS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PRIMECAP Odyssey Funds7,368,2120 00For
Federated Hermes1,661,0000 00For
Charles Schwab410,5580 00For
Putnam197,0850 00For
Altium Capital Management LP82,2710 00For
John Hancock28,6900 00For
Global X23,8270 00For
Harbor ETF Trust22,5740 00For
Exchange Place Advisors Trust20,3900 00For
CLEARWATER INVESTMENT TRUST15,8200 00For
Guardian Variable Products Trust15,4000 00For
New York Life10,0610 00For
Bridge Builder Trust9,9480 00For
SEI8,8000 00For
Brighthouse00 8,4570Abstain
EA Series Trust1,4240 00For
NORTHERN LIGHTS FUND TRUST II1,3890 00For
JPMorgan1,2070 00For
Pacer Funds Trust1,0100 00For
Nationwide4860 00For
WILSHIRE MUTUAL FUNDS INC2310 00For
Principal1020 00For

Largest RHYTHM PHARMACEUTICALS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 60,972,909 shares outstanding at the time of that meeting.

Fund voting reports: top RHYTHM PHARMACEUTICALS INC. shareholders by shares voted on “Elect Christophe R. Jean”, 2023-2024
#Asset manager % of shares outstanding
1PRIMECAP Odyssey Funds 12.08%
2Federated Hermes 2.72%
3Charles Schwab 0.67%
4Putnam 0.32%
5John Hancock 0.05%
6Global X 0.04%
7Harbor ETF Trust 0.04%
8Exchange Place Advisors Trust 0.03%
9CLEARWATER INVESTMENT TRUST 0.03%
10Guardian Variable Products Trust 0.03%
Institutional-manager reports: top RHYTHM PHARMACEUTICALS INC. shareholders by shares voted on “Approval, on an advisory (non-binding) basis, of the compensation of the named executive…”, 2023-2024
#Asset manager % of shares outstanding
1PRIMECAP MANAGEMENT CO/CA/ 12.67%
2Federated Hermes 2.72%
3PERCEPTIVE ADVISORS LLC 2.56%
4ORBIMED ADVISORS LLC 1.16%
5Opaleye Management Inc. 0.83%
6Charles Schwab 0.67%
7Northern Trust 0.66%
8Cormorant Asset Management, LP 0.65%
9Goldman Sachs 0.60%
10Putnam 0.34%

Reported RHYTHM PHARMACEUTICALS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

RHYTHM PHARMACEUTICALS INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
Entities affiliated with PRIMECAP Management Company 13.21% DEF14A
Entities affiliated with Baker Bros. Advisors LP 10.49% DEF14A
BlackRock 10.34% 13F
PRIMECAP MANAGEMENT CO/CA/ 9.49% 13G
Baker Bros. Advisors LP 9.19% 13G
Entities affiliated with RA Capital Management, LLC 8.74% DEF14A
Entities affiliated with Perceptive Advisors LLC. 8.44% DEF14A
Vanguard Group 8.19% 13F
Perceptive Advisors LLC 7.25% 13G
Entities affiliated with The Vanguard Group 5.29% DEF14A

Percentages above are of 60,972,909 shares outstanding, as reported by RHYTHM PHARMACEUTICALS INC. on its Form 10-Q dated May 1, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from RHYTHM PHARMACEUTICALS INC.’s 10-Q dated May 1, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

RHYTHM PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

proxyvotesnow.com, “RHYTHM PHARMACEUTICALS (RYTM) 2024 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/rhythm-pharmaceuticals-inc/2024 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.